MIRM logo

Mirum Pharmaceuticals, Inc. (MIRM)

Profile

Full Name

Mirum Pharmaceuticals, Inc.

Ticker

NASDAQ: MIRM

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 18, 2019

Indexes

Not included

Website

https://www.mirumpharma.com

Employees

334

Key Details

Price

$75.99(+1.48%)

Market cap

$3.82B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$336.89M(+80.76% YoY)

Annual EPS

-$1.85(+53.75% YoY)

PE ratio

-

Next earnings date

Nov 10, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $75.99
    MIRM price is $75.99

    30-Day Relative Volume

    0.59
    MIRM 30-day relative volume is 0.59

    Price Performance

    Price Most recent change

    +1.48%
    MIRM price was up +1.48% on Sep 11, 2025

    Price YTD change

    +83.77%
    MIRM price is up +83.77% since January 1st

    Price 1-year change

    +81.32%
    MIRM price is up +81.32% year-on-year

    Price 3-year change

    +202.15%
    MIRM price is up +202.15% over the past 3 years

    Price Range

    Price All-time high

    $78.09
    MIRM price is currently -2.70% below its historical high of $78.09

    Price 3-year low

    $17.32
    MIRM price is currently +338.87% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $3.82B
    MIRM market capitalization is $3.82 billion

    Market cap 3-year change

    +313.02%
    MIRM market capitalization is up +313.02% over the past 3 years

    Market cap All-time high

    $3.90B
    MIRM market capitalization is currently -2.19% below its historical high of $3.90 billion

    Market cap sector rank

    86.81%
    MIRM market capitalization is higher than 86.81% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +5.3%
    MIRM shares outstanding is up +5.3% year-on-year

    Shares Outstanding 3-Year Change

    +36.69%
    MIRM shares outstanding is up +36.69% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.79
    MIRM beta is 0.79

    200-day SMA

    $49.34
    MIRM price is currently +54.01% above its 200-day simple moving average

    50-day SMA

    $61.21
    MIRM price is currently +24.14% above its 50-day simple moving average

    RSI

    69.45
    MIRM 14-day relative strength index is 69.45

    Volume

    0.59
    MIRM 30-day relative volume is 0.59

    ATR

    $2.61
    MIRM average true range is $2.61

    10-day Historical Volatility

    29.73%
    MIRM 10-day historical volatility is 29.73%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $336.89M
    MIRM annual revenue is $336.89 million

    Revenue Analysts estimate

    $503.75M
    MIRM annual revenue is currently -33.12% lower than the consensus analysts' forecast

    Revenue 1-year change

    +80.76%
    MIRM annual revenue is up +80.76% year-on-year

    Revenue Sector rank

    78.43%
    MIRM annual revenue is higher than 78.43% of companies in Healthcare sector

    EPS

    EPS

    -$1.85
    MIRM annual earnings per share is -$1.85

    EPS Analysts estimate

    -$0.75
    MIRM annual earnings per share is currently +145.72% higher than the consensus analysts' forecast

    EPS 1-year change

    +53.75%
    MIRM annual earnings per share is up +53.75% year-on-year

    EPS Sector rank

    38.44%
    MIRM annual earnings per share is higher than 38.44% of companies in Healthcare sector

    Profit

    Gross profit

    $254.72M
    MIRM annual gross profit is $254.72 million

    Gross margin

    75.61%
    MIRM annual gross profit margin is 75.61%

    Operating profit

    -$87.61M
    MIRM annual operating income is -$87.61 million

    Operating margin

    -26.00%
    MIRM annual operating profit margin is -26.00%

    Net income

    -$87.94M
    MIRM annual net profit is -$87.94 million

    Net margin

    -26.10%
    MIRM annual net profit margin is -26.10%

    Expenses

    Total expenses

    $424.83M
    MIRM annual total expenses is $424.83 million

    Operating expenses

    $342.32M
    MIRM annual total operating expenses is $342.32 million

    Cost of goods sold

    $82.17M
    MIRM annual cost of goods sold is $82.17 million

    Selling, general & administrative expenses

    $0.00
    MIRM annual SGA is $0.00

    Depreciation and amortization

    $23.63M
    MIRM annual depreciation & amortization is $23.63 million

    Interest expense

    $0.00
    MIRM annual interest expense is $0.00

    Income tax

    $1.03M
    MIRM annual income tax is $1.03 million

    EBIT & EBITDA

    EBIT

    -$87.61M
    MIRM annual earnings before interest & taxes is -$87.61 million

    EBITDA

    -$63.98M
    MIRM annual EBITDA is -$63.98 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $670.75M
    MIRM annual total assets is $670.75 million

    Non current assets

    $277.97M
    MIRM annual long term assets is $277.97 million

    Current assets

    $392.79M
    MIRM annual total current assets is $392.79 million

    Cash and cash equivalents

    $222.50M
    MIRM annual cash & cash equivalents is $222.50 million

    Accounts receivable

    $78.29M
    MIRM annual accounts receivable is $78.29 million

    Inventory

    $22.40M
    MIRM annual inventory is $22.40 million

    Liabilities

    Total liabilities

    $445.11M
    MIRM annual total liabilities is $445.11 million

    Long term liabilities

    $318.56M
    MIRM annual total long term liabilities is $318.56 million

    Current liabilities

    $126.55M
    MIRM annual total current liabilities is $126.55 million

    Accounts payable

    $14.62M
    MIRM annual accounts payable is $14.62 million

    Debt

    Total debt

    $317.76M
    MIRM annual total debt is $317.76 million

    Total debt 1-year change

    +3.12%
    MIRM annual total debt is up +3.12% year-on-year

    Long term debt

    $316.05M
    MIRM annual long term debt is $316.05 million

    Short term debt

    $1.71M
    MIRM annual short term debt is $1.71 million

    Equity & Capital

    Shareholders equity

    $225.64M
    MIRM annual stockholders equity is $225.64 million

    Book value

    $225.64M
    MIRM annual book value is $225.64 million

    Retained earnings

    -$644.18M
    MIRM annual retained earnings is -$644.18 million

    Working capital

    $266.24M
    MIRM annual working capital is $266.24 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $10.32M
    MIRM annual cash flow from operations is $10.32 million

    Cash from operations 1-year change

    +114.55%
    MIRM annual cash flow from operations is up +114.55% year-on-year

    Cash from investing

    -$90.13M
    MIRM annual cash flow from investing activities is -$90.13 million

    Cash from investing 1-year change

    +15.93%
    MIRM annual cash flow from investing activities is up +15.93% year-on-year

    Cash from financing

    $17.70M
    MIRM annual cash flow from financing activities is $17.70 million

    Cash from financing 1-year change

    -94.74%
    MIRM annual cash flow from financing activities is down -94.74% year-on-year

    CAPEX

    CAPEX

    $20.99M
    MIRM annual capital expenditures is $20.99 million

    CAPEX 1-year change

    +4.4%
    MIRM annual capital expenditures is up +4.4% year-on-year

    Free Cash Flow

    Free cash flow

    -$10.67M
    MIRM annual free cash flow is -$10.67 million

    Free cash flow 1-year change

    +88.28%
    MIRM annual free cash flow is up +88.28% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    75.61%
    MIRM annual gross profit margin is 75.61%

    Operating margin

    -26.00%
    MIRM annual operating profit margin is -26.00%

    Net margin

    -26.10%
    MIRM annual net profit margin is -26.10%

    ROA & ROE

    ROA

    -13.35%
    MIRM annual return on assets is -13.35%

    ROE

    -37.08%
    MIRM annual return on equity is -37.08%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    MIRM price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    MIRM price to earnings ratio is unknown

    PB Ratio

    PB ratio

    14.96
    MIRM price to book ratio is 14.96

    PB ratio Sector rank

    92.75%
    MIRM price to book ratio is higher than 92.75% of companies in Healthcare sector

    PS Ratio

    PS ratio

    8.90
    MIRM price to sales ratio is 8.90

    PS ratio Sector rank

    70.84%
    MIRM price to sales ratio is higher than 70.84% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $3.83B
    MIRM enterprise value is $3.83 billion

    Enterprise value Sector rank

    86.14%
    MIRM enterprise value is higher than 86.14% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -203.91
    MIRM EV/EBITDA is -203.91

    EV/EBITDA Sector rank

    0.54%
    MIRM EV/EBITDA is higher than 0.54% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    3.10
    MIRM annual current ratio is 3.10

    Quick ratio

    2.93
    MIRM annual quick ratio is 2.93

    Leverage

    Debt to equity

    1.41
    MIRM annual debt to equity ratio is 1.41

    Interest coverage ratio

    -
    MIRM annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    4
    MIRM piotroski f-score is 4

    Altman Z-Score

    4.35
    MIRM altman z-score is 4.35

    Analyst ratings

    Recent major analysts updates

    Aug 8, 25 Evercore ISI Group
    Outperform
    Aug 7, 25 Raymond James
    Strong Buy
    Aug 7, 25 JMP Securities
    Market Outperform
    Aug 7, 25 HC Wainwright & Co.
    Buy
    May 13, 25 Raymond James
    Strong Buy
    May 9, 25 JMP Securities
    Market Outperform
    Feb 28, 25 HC Wainwright & Co.
    Buy
    Feb 27, 25 Baird
    Outperform
    Feb 24, 25 Citizens Capital Markets
    Market Outperform
    Nov 13, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with MIRM included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    • What is the ticker symbol for Mirum Pharmaceuticals, Inc.?
    • Does Mirum Pharmaceuticals, Inc. pay dividends?
    • What sector is Mirum Pharmaceuticals, Inc. in?
    • What industry is Mirum Pharmaceuticals, Inc. in?
    • What country is Mirum Pharmaceuticals, Inc. based in?
    • When did Mirum Pharmaceuticals, Inc. go public?
    • Is Mirum Pharmaceuticals, Inc. in the S&P 500?
    • Is Mirum Pharmaceuticals, Inc. in the NASDAQ 100?
    • Is Mirum Pharmaceuticals, Inc. in the Dow Jones?
    • When was Mirum Pharmaceuticals, Inc.'s last earnings report?
    • When does Mirum Pharmaceuticals, Inc. report earnings?

    What is the ticker symbol for Mirum Pharmaceuticals, Inc.?

    The ticker symbol for Mirum Pharmaceuticals, Inc. is NASDAQ:MIRM

    Does Mirum Pharmaceuticals, Inc. pay dividends?

    No, Mirum Pharmaceuticals, Inc. does not pay dividends

    What sector is Mirum Pharmaceuticals, Inc. in?

    Mirum Pharmaceuticals, Inc. is in the Healthcare sector

    What industry is Mirum Pharmaceuticals, Inc. in?

    Mirum Pharmaceuticals, Inc. is in the Biotechnology industry

    What country is Mirum Pharmaceuticals, Inc. based in?

    Mirum Pharmaceuticals, Inc. is headquartered in United States

    When did Mirum Pharmaceuticals, Inc. go public?

    Mirum Pharmaceuticals, Inc.'s initial public offering (IPO) was on July 18, 2019

    Is Mirum Pharmaceuticals, Inc. in the S&P 500?

    No, Mirum Pharmaceuticals, Inc. is not included in the S&P 500 index

    Is Mirum Pharmaceuticals, Inc. in the NASDAQ 100?

    No, Mirum Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

    Is Mirum Pharmaceuticals, Inc. in the Dow Jones?

    No, Mirum Pharmaceuticals, Inc. is not included in the Dow Jones index

    When was Mirum Pharmaceuticals, Inc.'s last earnings report?

    Mirum Pharmaceuticals, Inc.'s most recent earnings report was on August 6, 2025

    When does Mirum Pharmaceuticals, Inc. report earnings?

    The next expected earnings date for Mirum Pharmaceuticals, Inc. is November 10, 2025
    On this page